Literature DB >> 22126562

Implications of PSA kinetics for an adverse pathology after radical prostatectomy.

Stavros Sfoungaristos1, Petros Perimenis.   

Abstract

OBJECTIVE: To determine and compare the prognostic value of PSA density, PSA velocity and free/total PSA ratio in predicting adverse pathological findings after radical prostatectomy. MATERIALS: We analyzed the medical records of 142 patients who underwent a radical prostatectomy from May 2009 until February of 2011. After exclusion of of them for defined criteria, preoperative PSA and its derivatives were analysed for their ability to predict unfavorable pathology after radical prostatectomy.
RESULTS: From the 105 patients included in the analysis, 23.8% had extraprostatic cancer extension, 8.6% had seminal vesicle involvement and positive surgical margins found in 38.1% of them. PSA density value >0.2 ng/ml2 was the solitary and most significant predictor for surgical margin status (p=0.015) and for extracapsular disease (p=0.050) as well, in multivariate analysis. Preoperative PSA was the only significant parameter for seminal vesicle invasion prediction (p=0.033). Both PSA velocity and ratio failed to reach predictive significance in all analyses.
CONCLUSION: The present results demonstrate a significance of PSA density in preoperative estimation of adverse pathological findings in patients who undergo radical prostatectomy for clinically localized prostate cancer. A value of 0.2 ng/ml2 seems to be a reliable cutoff. PSA density is a bettgerer predictor than PSA velocity and the PSA ratio.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126562

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  1 in total

1.  Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?

Authors:  Sang Jin Kim; Tae Yoong Jeong; Dae Seon Yoo; Jinsung Park; Seok Cho; Seok Ho Kang; Sang Hyub Lee; Seung Hyun Jeon; Tchun Yong Lee; Sung Yul Park
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.